These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 30602058)

  • 1. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
    Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
    Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.
    Erstad DJ; Chiang YJ; Witt RG; Cope B; Nassif EF; Scally CP; Torres KE; Feig BW; Hunt KK; Bishop AJ; Guadagnolo BA; Roland CL; Keung EZ
    Ann Surg Oncol; 2023 Feb; 30(2):926-940. PubMed ID: 36115928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.
    Callegaro D; Raut CP; Ajayi T; Strauss D; Bonvalot S; Ng D; Stoeckle E; Fairweather M; Rutkowski P; van Houdt WJ; Gelderblom H; Sangalli C; Hayes A; Honoré C; Gladdy RA; Fau M; Haas R; Tzanis D; Miah AB; Chung P; Baldini EH; Marreaud S; Litiere S; Swallow CJ; Gronchi A
    Ann Surg; 2023 Jul; 278(1):127-134. PubMed ID: 35833413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
    Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
    Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
    Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
    Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
    Nussbaum DP; Rushing CN; Lane WO; Cardona DM; Kirsch DG; Peterson BL; Blazer DG
    Lancet Oncol; 2016 Jul; 17(7):966-975. PubMed ID: 27210906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative radiotherapy in the management of retroperitoneal liposarcoma.
    Ecker BL; Peters MG; McMillan MT; Sinnamon AJ; Zhang PJ; Fraker DL; Levin WP; Roses RE; Karakousis GC
    Br J Surg; 2016 Dec; 103(13):1839-1846. PubMed ID: 27682864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age and subtype in outcome of operable liposarcoma.
    Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
    Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
    Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
    Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
    Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
    World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
    Nassif EF; Cope B; Traweek R; Witt RG; Erstad DJ; Scally CP; Thirasastr P; Zarzour MA; Ludwig J; Benjamin R; Bishop AJ; Guadagnolo BA; Ingram D; Wani K; Wang WL; Lazar AJ; Torres KE; Hunt KK; Feig BW; Roland CL; Somaiah N; Keung EZ
    Int J Cancer; 2022 Jun; 150(12):2012-2024. PubMed ID: 35128664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of standard and novel radiotherapy approaches in management of retroperitoneal sarcomas.
    Wiltink LM; Spalek MJ; Sangalli C; Haas RL
    Eur J Surg Oncol; 2023 Jun; 49(6):1111-1114. PubMed ID: 36115783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Are the Results of Resection of Localized Dedifferentiated Liposarcomas in the Extremities?
    Nakata E; Kunisada T; Hasei J; Nakahara R; Yanai H; Toji T; Inoue Ct H; Ozaki T
    Clin Orthop Relat Res; 2020 Nov; 478(11):2550-2561. PubMed ID: 33112583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
    Jour G; Gullet A; Liu M; Hoch BL
    Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low and moderate grade retroperitoneal liposarcoma: Is adjuvant radiotherapy associated with improved survival in patients undergoing R1 resection?
    Littau MJ; Bunn C; Kim P; Kulshrestha S; Tonelli C; Abdelsattar ZM; Luchette FA; Baker MS
    Am J Surg; 2022 Mar; 223(3):527-530. PubMed ID: 34974888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.
    Gronchi A; Miceli R; Allard MA; Callegaro D; Le Péchoux C; Fiore M; Honoré C; Sanfilippo R; Coppola S; Stacchiotti S; Terrier P; Casali PG; Le Cesne A; Mariani L; Colombo C; Bonvalot S
    Ann Surg Oncol; 2015 May; 22(5):1447-54. PubMed ID: 25300609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.